YOLFTbeta
NIBEC Co. Ltd

NIBEC Co. Ltd

138610 · KQ · Healthcare / Biotechnology

12,870.00KRW-240.00 (-1.83%)

Price History

Full chart

Market Stats

Previous Close13,110.00
Open13,190.00
Day Range12,820.00 – 13,680.00
52-Week Range11,230.00 – 54,300.00
Volume15.88K
Market Cap182.91B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.58
50-Day Avg15,294.60
200-Day Avg24,427.75

About

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is based in Jincheon-eup, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Chung Chong-Pyung Ph.D.
  • Employees96
  • HeadquartersIwol electricity-electronic Agro-industrial Complex, Jincheon-eup, South Korea, 27816, Korea
  • Websitehttps://nibec.co.kr

Leadership

  • Dr. Chung Chong-Pyung Ph.D.Chief Executive Officer · b. 1946

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.79B4.17B4.80B6.30B5.21B9.29B6.36B13.63B21.67B15.70B24.55B32.72B
Growth (%)--12.80%+15.11%+31.19%-17.37%+78.34%-31.55%+114.33%+59.04%-27.53%+56.33%+33.27%
Cost of Revenue3.89B3.24B4.00B4.35B4.75B5.31B4.62B6.60B8.64B7.44B11.87B11.94B
Gross Profit892.67M932.50M799.78M1.96B462.07M3.98B1.74B7.02B13.04B8.26B12.68B20.78B
Gross Margin18.65%22.34%16.65%31.03%8.87%42.83%27.39%51.53%60.15%52.60%51.65%63.52%
Operating Expense3.92B2.85B3.30B3.82B3.92B6.16B6.66B9.13B12.55B12.00B19.85B15.76B
Operating Income-3.02B-1.92B-2.50B-1.86B-3.46B-2.19B-4.92B-2.11B485.86M-3.73B-7.17B5.03B
Operating Margin-63.20%-45.98%-52.04%-29.58%-66.46%-23.54%-77.45%-15.47%2.24%-23.78%-29.21%15.36%
EBITDA--------976.47M75.06M-4.06B8.54B
EBITDA Margin--------4.51%0.48%-16.53%26.11%
Net Income-3.62B-2.43B-3.03B-2.57B-4.15B-2.73B-3.64B-5.74B-3.77B-6.28B-9.33B4.64B
Net Income Margin-75.65%-58.13%-63.01%-40.74%-79.61%-29.36%-57.22%-42.13%-17.38%-40.02%-37.99%14.19%
R&D148.91M113.69M251.73M640.63M1.20B-1.54B3.33B5.36B3.24B4.07B5.61B
R&D as % of Total Revenue3.11%2.72%5.24%10.16%23.12%-24.15%24.46%24.74%20.65%16.60%17.15%
Interest Expense000000198.41M1.83B2.50B2.88B2.04B506.19M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%3.12%13.41%11.53%18.33%8.32%1.55%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.15B19.43B22.97B25.75B22.32B35.73B53.08B53.28B75.20B66.80B62.45B63.00B
Total Liabilities9.07B8.61B13.13B13.39B11.74B8.33B21.24B25.93B38.40B37.96B30.22B17.18B
Total Equity5.08B10.82B9.84B12.36B10.58B27.40B31.84B27.34B36.80B28.84B32.23B45.82B
Cash1.22B2.32B4.61B5.28B858.97M4.50B20.95B15.55B27.25B21.29B23.22B22.05B
Total Debt-4.25B7.12B5.83B1.72B1.50B11.87B-----
Net Debt---------134.71M--

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-903.85M-2.13B-372.21M563.22M-2.31B-867.62M-501.66M817.97M5.44B-1.96B291.25M5.82B
Investing Cash Flow-676.23M-3.04B-2.78B-4.09B-2.35B-9.70B-4.38B-6.17B-6.81B-490.55M1.37B-
Financing Cash Flow712.75M6.06B5.42B4.24B240.47M14.28B21.87B-942.62M12.57B-3.83B-722.46M-
Capital Expenditure283.33M2.07B3.78B1.30B968.06M2.01B1.78B3.21B1.85B7.68B4.07B5.27B
Free Cash Flow------5.21B-4.94B-2.40B3.59B-9.64B-3.78B546.94M
FCF to OCF-----600.08%983.74%-292.87%66.07%491.76%-1298.77%9.40%

Earnings

Report DateSep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 16, 2016Nov 14, 2016Mar 10, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Mar 15, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 11, 2019May 9, 2019Jun 30, 2019Nov 14, 2019Mar 18, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual-147.60-149.97-62.65-57.43-65.31-147.55-122.43-166.99-167.11-454.40-235.69-233.06-168.40-171.57-62.91-108.35-103.00-160.75-80.25-56.74-162.13-192.1639.79-70.25-45.94-317.15-82.66-161.45-96.68-222.44-61.18-170.85-29.47-66.703.34-74.00-78.39-214.75-117.43-146.7832.76-348.15124.88104.6049.47-658.45-20.37-35.94-303.08-271.5823.00-88.11-585.62-244.48-138.35683.23-40.13-96.68101.0433.55
Surprise------------------------------------------------------------
Timing-------------------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hours--Pre-market--------------------------

Key Statistics & Ratios

Market Cap182.91B
Enterprise Value161.10B
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.09
Price / Book3.62
Revenue (TTM)22.60B
Gross Profit (TTM)11.19B
EBITDA1.05B
Profit Margin-0.10%
Operating Margin1.69%
Return on Equity-0.05%
Return on Assets-1.82%
Shares Outstanding11.37M
Shares Float9.17M
Beta0.58
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Apr 30, 2019768:653
  • Jul 29, 2015377:353